Thus, even secondary increases in TGF-β2 concentrations can modulate ECM composition, AH outflow, and IOP, most consistently reported in POAG and can also negatively impact outcomes of glaucoma surgery, such as trabeculectomy.38 The gene discussed is TGFB2; the disease is glaucoma.